Abstract
Introduction Supratentorial primitive neuroectodermal tumors (SPNET) are rare tumors accounting for only 2.5% of childhood brain tumors. The purpose of this study was to describe the range of treatment regimens used to treat pediatric SPNET in Canada and to identify prognostic factors for overall survival in this population. Methods This study was a retrospective clinical analysis of SPNET patients treated over the last 10 years in Canada. A questionnaire was developed and distributed to all institutions in Canada who treat pediatric patients. Data were collected for patients <19 years of age who were diagnosed and treated for SPNET between 1995 and 2005. Results Data were obtained for 48 eligible patients. The stages of patients for whom complete data were provided were 80, 3, and 16% for metastatic stage M0, M1, and M2/3, respectively. The best responses to therapy included complete response in 44%, partial response in 8%, still on therapy in 2%, progressive disease in 31%, toxic death in 2%, and no therapy given in 12%. The 4-year survival was 37.7 ± 7.6%. The factors associated with an increase in survival were the use of radiation therapy and chemotherapy, and age >2 years. Overall survival was not affected by metastatic disease at diagnosis, tumor site, or degree of initial resection. Conclusions Survival is poor in SPNET patients but highest in those who received chemotherapy and radiation therapy. Further studies are needed to improve the survival of these patients.
Similar content being viewed by others
References
Gaffney CC, Sloane JP, Bradley NJ, Bloom HJG (1985) Primitive neuroectodermal tumours of the cerebrum. J Neurooncol 3:23–33
Albright AL, Wisoff JH, Zeltzer P et al (1995) Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. Pediatr Neurosurg 22:1–7
Rorke LB, Trojanowski JQ, Lee VM et al (1997) Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 2:765–784
Jakacki RI (1999) Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Child Nerv Syst 15(10):586–591
Li MH, Bouffet E, Hawkins CE, Squire JA, Huang A (2005) Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma. Neurosurg Focus 19:E3
Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT (1996) Supratentorial primitive neuroectodermal tumors in children. J Neurooncol 29:75–84
Cohen BH, Zeltzer PM, Boyett JM et al (1995) Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a childrens’ cancer group randomized trial. J Clin Oncol 13:1687–1696
Albright AL, Wisoff JH, Zeltzer P et al (1995) Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. Pediatr Neurosurg 22:1–7
Jakacki R (1999) Pineal and nonpineal supratentorial primitive neuroectodermal tumors. Child Nerv Syst 15:586–591
Yang HJ, Nam DH, Wang KC, Kim YM, Chi JG, Cho BK (1999) Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors. Child Nerv Syst 15:377–383
Paulino AC, Melian E (1999) Medulloblastoma and supratentorial primitive neuroectodermal tumors, an institutional experience. Cancer 86:142–148
Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation and chemotherapy. Cancer 88:2189–2193
Geyer JR, Sposto R, Jennings M et al (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children’s Cancer Group. J Clin Oncol 23:7621–7631
Pizer BL, Weston CL, Robinson KJ et al (2006) Analysis of patients with supratentorial primitive neuro-ectodermal tumors entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 42:1120–1128
Timmermann B, Kortmann RD, Kuhl J et al (2002) Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20:842–849
Jakacki RI, Zeltzer PM, Boyett JM et al (1995) Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the childrens cancer group. J Clin Oncol 13:1377–1383
Marec-Berard B, Jouvet A, Thiesse P, Kalifa C, Doz F, Frappaz D (2002) Supratentorial embryonal tumors in children under 5 years of age: a SFOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol 38:83–90
Timmermann B, Kortmann RD, Kuhl J et al (2006) Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: Results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24:1554–1560
Duchatelier S, Wolf SM (2001) Diagnostic principles. In: Keating RF, Goodrich JT, Packer RJ (eds) Tumors of the pediatric central nervous system. Thieme, New York, pp 22–26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnston, D.L., Keene, D.L., Lafay-Cousin, L. et al. Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report. J Neurooncol 86, 101–108 (2008). https://doi.org/10.1007/s11060-007-9440-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9440-1